HLTRF
vs
A
0HF3
HLTRF
Over the past 12 months, HLTRF has underperformed 0HF3, delivering a return of +7% compared to the 0HF3's +23% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
HLTRF
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
HLS Therapeutics Inc
OTC:HLTRF
|
3.362
USD
|
|||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
331.63
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
HLTRF, 0HF3
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
HLS Therapeutics Inc
Revenue
|
|||||||||||
|
A
|
Amerisourcebergen Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
HLTRF, 0HF3
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
HLS Therapeutics Inc
OTC:HLTRF
|
|||||||||
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
HLS Therapeutics Inc | ||||
|
A
|
Amerisourcebergen Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
HLS Therapeutics Inc | ||||
|
A
|
Amerisourcebergen Corp | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
HLS Therapeutics Inc | ||||
|
A
|
Amerisourcebergen Corp | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
HLS Therapeutics Inc | ||||
|
A
|
Amerisourcebergen Corp | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
HLS Therapeutics Inc | ||||
|
A
|
Amerisourcebergen Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
HLTRF, 0HF3
Performance Gap
HLTRF, 0HF3
Performance By Year
HLTRF, 0HF3
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|